$460 Million is the total value of SECTOR GAMMA AS's 40 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRK | Buy | MERCK & CO INC | $40,955,000 | +12.3% | 499,141 | +4.9% | 8.90% | +3.8% |
| GILD | Buy | GILEAD SCIENCES INC | $40,517,000 | +87.8% | 681,538 | +129.4% | 8.80% | +73.6% |
| INCY | Buy | INCYTE CORP | $35,105,000 | +26.2% | 442,012 | +16.7% | 7.63% | +16.7% |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $24,360,000 | +12.1% | 333,558 | -4.3% | 5.29% | +3.6% |
| MDT | Buy | MEDTRONIC PLC | $22,856,000 | +8.2% | 206,006 | +0.9% | 4.97% | -0.0% |
| CAH | Sell | CARDINAL HEALTH INC | $21,391,000 | -16.4% | 377,270 | -24.0% | 4.65% | -22.7% |
| CVS | Sell | CVS HEALTH CORP | $20,128,000 | -5.4% | 198,873 | -3.5% | 4.37% | -12.5% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $17,509,000 | -17.5% | 395,335 | -20.9% | 3.80% | -23.7% |
| BIIB | Buy | BIOGEN INC | $17,258,000 | +8.0% | 81,945 | +23.0% | 3.75% | -0.2% |
| CNC | Buy | CENTENE CORP DEL | $16,389,000 | +8.6% | 194,664 | +6.3% | 3.56% | +0.4% |
| BRKR | Buy | BRUKER CORP | $16,201,000 | +18.6% | 251,952 | +54.8% | 3.52% | +9.7% |
| NUVA | Buy | NUVASIVE INC | $15,084,000 | +19.4% | 266,035 | +10.5% | 3.28% | +10.4% |
| ANTM | Sell | ANTHEM INC | $14,254,000 | -10.6% | 29,018 | -15.7% | 3.10% | -17.4% |
| CI | Buy | CIGNA CORP NEW | $13,986,000 | +46.8% | 58,370 | +40.7% | 3.04% | +35.7% |
| OGN | Sell | ORGANON & CO | $11,867,000 | -9.7% | 339,738 | -21.3% | 2.58% | -16.5% |
| QGEN | Buy | QIAGEN NV | $10,742,000 | -1.8% | 219,226 | +11.4% | 2.33% | -9.3% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $9,675,000 | – | 59,251 | +100.0% | 2.10% | – |
| ELAN | Buy | ELANCO ANIMAL HEALTH INC | $9,515,000 | -2.9% | 364,691 | +5.6% | 2.07% | -10.2% |
| ZBH | New | ZIMMER BIOMET HOLDINGS INC | $8,288,000 | – | 64,801 | +100.0% | 1.80% | – |
| AZN | New | ASTRAZENECA PLCsponsored adr | $8,226,000 | – | 124,000 | +100.0% | 1.79% | – |
| BIO | Buy | BIO RAD LABS INCcl a | $7,201,000 | -18.1% | 12,785 | +9.8% | 1.56% | -24.3% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $6,980,000 | +9.5% | 188,439 | -10.1% | 1.52% | +1.2% |
| BDX | Sell | BECTON DICKINSON & CO | $6,978,000 | -63.3% | 26,233 | -65.3% | 1.52% | -66.1% |
| UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $6,880,000 | +17.3% | 47,467 | +4.9% | 1.50% | +8.4% |
| PFE | Sell | PFIZER INC | $6,717,000 | -60.1% | 129,738 | -54.5% | 1.46% | -63.1% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $6,461,000 | -24.7% | 24,758 | -36.6% | 1.40% | -30.4% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $6,149,000 | -38.7% | 79,759 | -29.8% | 1.34% | -43.3% |
| ITCI | New | INTRA-CELLULAR THERAPIES INC | $4,947,000 | – | 80,843 | +100.0% | 1.08% | – |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $4,385,000 | +12.6% | 1,466,678 | -0.2% | 0.95% | +4.2% |
| PDCO | Buy | PATTERSON COS INC | $4,200,000 | +16.4% | 129,757 | +5.5% | 0.91% | +7.7% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $3,922,000 | -6.8% | 118,476 | +19.8% | 0.85% | -13.9% |
| RARE | New | ULTRAGENYX PHARMACEUTICAL IN | $3,357,000 | – | 46,221 | +100.0% | 0.73% | – |
| PTCT | New | PTC THERAPEUTICS INC | $2,980,000 | – | 79,864 | +100.0% | 0.65% | – |
| NVAX | Buy | NOVAVAX INC | $2,823,000 | +47.9% | 38,324 | +187.2% | 0.61% | +36.5% |
| XRAY | Sell | DENTSPLY SIRONA INC | $2,732,000 | -57.4% | 55,516 | -51.6% | 0.59% | -60.6% |
| QTRX | New | QUANTERIX CORP | $2,588,000 | – | 88,670 | +100.0% | 0.56% | – |
| New | SOMALOGIC INC | $2,416,000 | – | 301,224 | +100.0% | 0.52% | – | |
| VIR | Buy | VIR BIOTECHNOLOGY INC | $2,063,000 | +12.0% | 80,223 | +82.3% | 0.45% | +3.5% |
| ATRA | New | ATARA BIOTHERAPEUTICS INC | $1,149,000 | – | 123,713 | +100.0% | 0.25% | – |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $976,000 | -74.5% | 11,875 | -54.5% | 0.21% | -76.4% |
| BNTX | Exit | BIONTECH SEsponsored ads | $0 | – | -13,032 | -100.0% | -0.79% | – |
| LH | Exit | LABORATORY CORP AMER HLDGS | $0 | – | -23,377 | -100.0% | -1.73% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-06
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.